When the Thyroid Makes Too Much Hormone

An overactive thyroid (hyperthyroidism) means the gland is producing more thyroid hormone than the body needs. The pituitary responds by dialing TSH down — sometimes to nearly zero — but the thyroid keeps going anyway, overriding the normal feedback system. The result is a body running faster than it should: heart rate up, metabolism accelerated, nervous system on edge.

The symptoms of hyperthyroidism are almost the mirror image of hypothyroidism. Instead of fatigue and weight gain, patients typically notice anxiety, a racing or pounding heartbeat (palpitations), unintentional weight loss, heat intolerance, tremor in the hands, difficulty sleeping, and more frequent bowel movements. In older patients, the presentation can be subtler — sometimes just unexplained atrial fibrillation or new-onset heart failure with no other obvious cause.

🚨 Seek Emergency Care Thyroid storm (thyrotoxic crisis) is a rare but life-threatening complication of untreated or undertreated hyperthyroidism — typically triggered by illness, surgery, or stopping medication abruptly. Signs include a very high fever, extreme agitation or confusion, a heart rate above 140 beats per minute, vomiting, and diarrhea. This is a medical emergency requiring immediate hospital care.

What Causes Hyperthyroidism?

The most common cause by far is Graves' disease — an autoimmune condition in which the immune system produces antibodies that mimic TSH and continuously stimulate the thyroid to produce hormone, regardless of how much is already circulating. Graves' disease accounts for roughly 70–80% of all hyperthyroidism cases and is often accompanied by a diffusely enlarged thyroid gland (goiter). A subset of patients also develop Graves' ophthalmopathy — an inflammation behind the eyes that causes them to appear prominent or bulging, and which requires its own separate management.

Other causes include toxic nodular goiter — one or more nodules in the thyroid that become autonomous, producing hormone on their own without waiting for TSH instructions — and thyroiditis, an inflammation of the thyroid that temporarily releases stored hormone into the bloodstream. Thyroiditis typically resolves on its own and may briefly swing through a hypothyroid phase before the gland recovers.

How It's Diagnosed

When hyperthyroidism is suspected based on symptoms, TSH is the right first test — a suppressed or undetectable TSH is a strong signal. If TSH is low, free T4 and total T3 are checked to confirm the diagnosis and assess severity. Pinpointing the cause usually requires one more step:

📊 The Evidence — Diagnosing the Cause

Thyrotropin receptor antibodies (TRAb) — blood markers of the autoimmune attack in Graves' disease — have a sensitivity of 97.7% and specificity of 99.5% for diagnosing Graves' disease, making them the most accurate and cost-effective way to confirm the diagnosis when TSH is suppressed.[1] If TRAb is negative, or if nodules are felt on exam, a radioactive iodine uptake scan (RAIU) can help distinguish between causes: diffuse uptake throughout the gland points to Graves' disease, uptake concentrated in one spot suggests a toxic nodule, and very low or absent uptake suggests thyroiditis — where the hormone release comes from a damaged gland rather than active overproduction.[2]

Treating Hyperthyroidism: Three Options

Unlike hypothyroidism, where treatment is almost always lifelong hormone replacement, hyperthyroidism has three distinct treatment paths — and the right choice depends on the cause, the severity, patient age, whether pregnancy is involved, and personal preference. All three are effective.

Antithyroid Drugs

How: Methimazole (preferred) or PTU block the thyroid from making new hormone

Remission rate: ~40–50% after 12–18 months

Advantages: No radiation, no surgery, chance of lasting remission, outpatient treatment

Drawbacks: ~50% relapse rate; rare but serious risk of agranulocytosis (dangerous drop in white blood cells)

Radioactive Iodine

How: A single dose of radioactive iodine (I-131) is swallowed; the thyroid absorbs it and is gradually destroyed

Advantages: Definitive, low cost, outpatient

Drawbacks: Causes permanent hypothyroidism in >80% of patients; 15–20% risk of triggering or worsening Graves' eye disease; not safe in pregnancy

Surgery

How: Removal of all or most of the thyroid gland (thyroidectomy)

Advantages: Rapid, definitive; preferred when a suspicious nodule is present, the goiter is very large, or eye disease is significant

Drawbacks: Permanent hypothyroidism; 1–4% risk of permanent hypoparathyroidism; risk of vocal cord nerve injury
📊 The Evidence — Choosing a Treatment

Antithyroid drugs are increasingly the preferred first-line approach for Graves' disease globally, partly because they offer the possibility of remission without permanent consequences, and partly because long-term low-dose therapy — used for 5–10 years rather than the traditional 12–18 months — is emerging as a safe strategy for patients who relapse after stopping.[3]

The most important practical distinction between antithyroid drugs and radioactive iodine involves the eyes. In patients who already have Graves' ophthalmopathy, radioactive iodine carries a 15–20% risk of making it worse. For those patients, antithyroid drugs or surgery are generally preferred.[2][4]

For toxic nodular disease — where one or more autonomous nodules are driving overproduction — the situation is different. Unlike Graves' disease, toxic nodules do not go into remission on their own, so antithyroid drugs would need to be taken indefinitely. Radioactive iodine or surgery is generally the preferred long-term approach, though long-term low-dose drug therapy is increasingly used in older patients or those who are not good surgical candidates.[3]

Subclinical Hyperthyroidism

Subclinical hyperthyroidism — a suppressed TSH with normal free T4 and T3, and no obvious symptoms — sits in a gray zone similar to subclinical hypothyroidism. The USPSTF recommends against routine treatment. Other guidelines are more nuanced: treatment is generally recommended when TSH is persistently below 0.1 mIU/L, particularly in older patients, because the cardiovascular and bone risks at that level of TSH suppression are meaningful.[1] I cover those risks in detail in Post 1.4.

My Synthesis The choice between antithyroid drugs, radioactive iodine, and surgery is one of the few areas in thyroid medicine where the evidence genuinely supports multiple approaches and patient preference legitimately drives the decision. My starting point for most Graves' disease patients is antithyroid drugs — specifically methimazole — because it preserves options. If a patient goes into remission, great. If they relapse, we can discuss radioactive iodine or surgery with full information. What I'm watchful for is eye disease: if there's any sign of Graves' ophthalmopathy, I steer away from radioactive iodine.

Thyroid Nodules: Common, Usually Benign, Often Overtreated

A thyroid nodule is a growth within the thyroid gland — a lump that feels or looks different from the surrounding tissue. They are extraordinarily common. Most people don't know they have one until it turns up incidentally on an ultrasound or CT scan done for something else entirely.

65%
of the general population has at least one thyroid nodule detectable by ultrasound [3]
5–10%
of thyroid nodules contain cancer — and most thyroid cancers are slow-growing and unlikely to cause harm [4]
98.5%
five-year survival rate for thyroid cancer — one of the highest of any cancer [5]

The challenge with thyroid nodules is not finding them — ultrasound is extraordinarily sensitive and will detect nodules in almost anyone you look closely enough. The challenge is figuring out which ones actually matter, because the vast majority never will.

The Screening Problem

South Korea offers the most striking real-world example of what happens when thyroid nodule screening becomes widespread. After implementing a national cancer screening program in the 1990s that included thyroid ultrasound, thyroid cancer diagnoses skyrocketed — increasing 15-fold over two decades. Thyroid cancer became one of the most commonly "diagnosed" cancers in the country. Thyroid cancer mortality didn't change at all.

📊 The Evidence — Against Routine Screening

The US Preventive Services Task Force issued a Grade D recommendation against screening for thyroid cancer in asymptomatic adults — meaning the evidence shows harms outweigh any benefits.[5] Despite a 4.5% annual increase in thyroid cancer detection over the past decade, mortality has remained essentially flat at approximately 0.5 deaths per 100,000 people per year. The USPSTF found no direct evidence that screening improves health outcomes.[5]

The harms of finding nodules through routine screening are real and quantifiable. Thyroid surgery — even when performed by experienced surgeons — carries a 2.1–5.9% risk of permanent hypoparathyroidism (damage to the glands that regulate calcium) and a 1.0–2.1% risk of permanent vocal cord nerve injury per operation.[6] Patients also face lifelong thyroid hormone replacement and, in some cases, radioactive iodine therapy with its own side effect profile. These are real harms caused by treating cancers that would most likely never have caused any problems.[6]

When a Nodule Actually Needs Attention

The right trigger for thyroid ultrasound is a clinical finding — not a desire to screen. Ultrasound is appropriate when a nodule can be felt on exam, when the thyroid gland is enlarged, when there's suspicious lymph node swelling in the neck, or when a nodule turns up incidentally on imaging done for another reason. In those cases, the ultrasound is evaluating a known or suspected finding — not hunting for occult disease in an asymptomatic person.[1][4]

When a nodule is found and requires further evaluation, the decision about whether to biopsy (fine needle aspiration, or FNA) is guided by ultrasound characteristics — size, shape, calcifications, borders — not by size alone. Most nodules, even fairly large ones, have features that are reassuringly benign and can be followed with periodic ultrasound rather than biopsied immediately.

⚠ High-Risk Features That Do Warrant Evaluation Certain patients do warrant closer surveillance regardless of symptoms: a personal history of radiation to the head or neck, a family history of thyroid cancer or certain inherited cancer syndromes, and nodules with specific ultrasound features suggesting higher cancer risk. If any of these apply to you and you haven't been evaluated, that's worth raising with your doctor — not because cancer is likely, but because the risk profile is different enough to warrant a closer look.
My Synthesis Incidental thyroid nodules are one of the most common conversations I have in primary care, and one of the most important things I can do is help patients understand that finding one is not the same as finding cancer — and that finding cancer is not the same as needing aggressive treatment. Most thyroid cancers are papillary microcarcinomas that grow so slowly they would never cause symptoms in a person's lifetime. The evidence increasingly supports active surveillance — watching and waiting — over immediate surgery for low-risk cancers. The goal of evaluation is to identify the rare nodule that actually needs intervention, not to treat everything we can find.